Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172718 | SCV000051329 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000041013 | SCV000064704 | benign | not specified | 2014-11-20 | criteria provided, single submitter | clinical testing | p.Glu4076Lys in exon 45A of TTN: This variant is not expected to have clinical s ignificance because it has been identified in 1.5% (248/16608) of South Asian ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs144690298). |
Gene |
RCV000041013 | SCV000238104 | uncertain significance | not specified | 2014-10-06 | criteria provided, single submitter | clinical testing | Missense variants in the TTN gene are considered 'unclassified' if they are not previously reported in the literature and do not have >1% frequency in the population to be considered a polymorphism. Research indicates that truncating mutations in the TTN gene are expected to account for approximately 25% of familial and 18% of sporadic idiopathic DCM; however, truncating variants in the TTN gene have been reported in approximately 3% of reported control alleles. There has been little investigation into non-truncating variants. (Herman D et al. Truncations of titin causing dilated cardiomyopathy. N Eng J Med 366:619-628, 2012) The variant is found in CARDIOMYOPATHY panel(s). |
Ce |
RCV000172718 | SCV004011282 | benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | TTN: BP4, BS1, BS2 |
Clinical Genetics, |
RCV000041013 | SCV001919166 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000041013 | SCV001965241 | benign | not specified | no assertion criteria provided | clinical testing |